Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% | -.--% | -.--% |
24/05 | JOHNSON MATTHEY : Higher transformation costs take their toll | |
23/05 | JOHNSON MATTHEY : ICEs might stay longer |
Strengths
- This company will be of major interest to investors in search of a high dividend stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- Revenue estimates are regularly revised downwards for the current and coming years.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 405.66Cr | - | ||
+18.74% | 6.73TCr | A- | ||
-0.84% | 4.85TCr | A- | ||
+23.56% | 4.42TCr | B+ | ||
+27.71% | 2.81TCr | A- | ||
+7.64% | 1.92TCr | C+ | ||
+11.70% | 1.68TCr | B+ | ||
-6.51% | 1.59TCr | B+ | ||
-27.02% | 1.48TCr | A- | ||
-18.11% | 1.39TCr | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- JMAT Stock
- JMAT Stock
- Ratings Johnson Matthey Plc